-
Je něco špatně v tomto záznamu ?
Soluble RAGEs and cardiovascular risk factors in adult offspring of patients with premature coronary heart disease
P. Karnosová, M. Mateřánková, J. Seidlerová, O. Mayer, J. Filipovský, V. Karnos,
Jazyk angličtina Země Velká Británie
Typ dokumentu časopisecké články, práce podpořená grantem
NLK
Medline Complete (EBSCOhost)
od 1998-04-20
ROAD: Directory of Open Access Scholarly Resources
od 1992
- MeSH
- biologické markery krev MeSH
- dítě postižených rodičů * MeSH
- dospělé děti * MeSH
- dospělí MeSH
- hodnocení rizik MeSH
- koronární nemoc * MeSH
- lidé středního věku MeSH
- lidé MeSH
- mladý dospělý MeSH
- průřezové studie MeSH
- receptor pro konečné produkty pokročilé glykace krev MeSH
- rizikové faktory kardiovaskulárních chorob MeSH
- studie případů a kontrol MeSH
- věk při počátku nemoci MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mladý dospělý MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
Purpose: Advanced glycation end products (AGEs) are a heterogeneous group of highly oxidant compounds which can potentiate microvascular and macrovascular complications through the formation of irreversible cross-links between molecules in the basal membrane and also by engaging the receptor for AGEs (RAGE). Soluble receptor for AGEs (sRAGE) is suggested to have a protective role neutralizing the toxic action of AGEs. We aimed to investigate differences in plasma levels of sRAGE alongside with classic cardiovascular risk factors between offspring of patients with early onset of coronary heart disease (CHD) and healthy controls.Materials and methods: In a cross-sectional design, we examined 114 adult offspring of patients with premature CHD and 194 controls. Concentrations of soluble RAGE were quantified by ELISA methods. Aortic PWV was measured using Sphygmocor device. Multivariate logistic regressions were used to compare differences between the offspring and controls.Results: In the offspring group there were more men (p = 0.023), both groups had similar age (28.5 vs. 28.9 years; p = 0.51). After adjustment for covariates, we observed significantly higher aPWV (6.17 vs. 5.82 m s-1; p = 0.001) and lower sRAGE (1308.11 vs. 1475.59; p = 0.009) in the offspring group compared to controls. The significant determinants of the intergroup difference were sRAGE (p = 0.0017), aPWV (p = 0.011) and current smoking (p = 0.0053).Conclusion: Offspring of patients with early onset of CHD compared to age-matched healthy controls had significantly lower sRAGE levels suggesting a shift in the oxidative balance between stressors and defence mechanisms that may influence a higher cardiovascular risk in the future. The measurement of sRAGE might be a valuable predictor for more precise stratification of cardiovascular risk.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc20028293
- 003
- CZ-PrNML
- 005
- 20250325143240.0
- 007
- ta
- 008
- 210105s2020 xxk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1080/08037051.2019.1685372 $2 doi
- 035 __
- $a (PubMed)31691578
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Karnosová, Petra, $u Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic. Biomedical Centre, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic. $d 1985- $7 xx0330667
- 245 10
- $a Soluble RAGEs and cardiovascular risk factors in adult offspring of patients with premature coronary heart disease / $c P. Karnosová, M. Mateřánková, J. Seidlerová, O. Mayer, J. Filipovský, V. Karnos,
- 520 9_
- $a Purpose: Advanced glycation end products (AGEs) are a heterogeneous group of highly oxidant compounds which can potentiate microvascular and macrovascular complications through the formation of irreversible cross-links between molecules in the basal membrane and also by engaging the receptor for AGEs (RAGE). Soluble receptor for AGEs (sRAGE) is suggested to have a protective role neutralizing the toxic action of AGEs. We aimed to investigate differences in plasma levels of sRAGE alongside with classic cardiovascular risk factors between offspring of patients with early onset of coronary heart disease (CHD) and healthy controls.Materials and methods: In a cross-sectional design, we examined 114 adult offspring of patients with premature CHD and 194 controls. Concentrations of soluble RAGE were quantified by ELISA methods. Aortic PWV was measured using Sphygmocor device. Multivariate logistic regressions were used to compare differences between the offspring and controls.Results: In the offspring group there were more men (p = 0.023), both groups had similar age (28.5 vs. 28.9 years; p = 0.51). After adjustment for covariates, we observed significantly higher aPWV (6.17 vs. 5.82 m s-1; p = 0.001) and lower sRAGE (1308.11 vs. 1475.59; p = 0.009) in the offspring group compared to controls. The significant determinants of the intergroup difference were sRAGE (p = 0.0017), aPWV (p = 0.011) and current smoking (p = 0.0053).Conclusion: Offspring of patients with early onset of CHD compared to age-matched healthy controls had significantly lower sRAGE levels suggesting a shift in the oxidative balance between stressors and defence mechanisms that may influence a higher cardiovascular risk in the future. The measurement of sRAGE might be a valuable predictor for more precise stratification of cardiovascular risk.
- 650 _2
- $a dospělí $7 D000328
- 650 12
- $a dospělé děti $7 D032721
- 650 _2
- $a věk při počátku nemoci $7 D017668
- 650 _2
- $a biologické markery $x krev $7 D015415
- 650 _2
- $a studie případů a kontrol $7 D016022
- 650 12
- $a dítě postižených rodičů $7 D016241
- 650 12
- $a koronární nemoc $7 D003327
- 650 _2
- $a průřezové studie $7 D003430
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a rizikové faktory kardiovaskulárních chorob $7 D000082742
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a receptor pro konečné produkty pokročilé glykace $x krev $7 D000067759
- 650 _2
- $a hodnocení rizik $7 D018570
- 650 _2
- $a mladý dospělý $7 D055815
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Mateřánková, Markéta $u Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic. Biomedical Centre, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic.
- 700 1_
- $a Seidlerová, Jitka $u Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic. Biomedical Centre, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic.
- 700 1_
- $a Mayer, Otto $u Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic. Biomedical Centre, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic.
- 700 1_
- $a Filipovský, Jan $u Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic. Biomedical Centre, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic.
- 700 1_
- $a Karnos, Václav $u Department of Surgery, University Hospital in Pilsen, Pilsen, Czech Republic.
- 773 0_
- $w MED00000810 $t Blood pressure $x 1651-1999 $g Roč. 29, č. 2 (2020), s. 87-94
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/31691578 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20210105 $b ABA008
- 991 __
- $a 20250325143241 $b ABA008
- 999 __
- $a ok $b bmc $g 1608628 $s 1119473
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2020 $b 29 $c 2 $d 87-94 $e 20191106 $i 1651-1999 $m Blood pressure $n Blood Press $x MED00000810
- LZP __
- $a Pubmed-20210105